Nano Stocks

NanoCrystal® Technology Approved for use in Japan

by Kevin Rippey on Dec.14, 2009, under Nanotech Company Info, Pharmaceuticals

Elan’s (NYSE: ELN) NanoCrystal® technology has been approved for use in Japan. The approval comes as part of the approval for EMEND® a drug treatment for chemotherapy induced nausea. EMEND® is the first NanoCrystal® based drug to be approved in Japan. The stock traded up over 4.5% on the news today.

Full Story: Here

:

2 Comments for this entry

2 Trackbacks / Pingbacks for this entry

Leave a Reply

Looking for something?

Use the form below to search the site:

Still not finding what you're looking for? Drop a comment on a post or contact us so we can take care of it!

Archives

All entries, chronologically...